Healthcare
Aayush Wellness reports 10.6% rise in first-half income
Aayush Wellness experienced an increase in consolidated income and profit for the first half of fiscal 2027. The company reported an impressive rise in both consolidated income and profit after tax. Standalone income also showed significant growth compared to the preceding quarter. Aayush Wellness is launching new products to expand its presence in preventive healthcare and nutraceutical markets.
Your old medical reports may reveal a disease risk you don't know about. Here's how AI can help
AI could help uncover hidden health risks by analysing years of old medical reports, blood tests, prescriptions and hospital records. Predictive AI models may identify patterns linked to conditions such as cardiac arrhythmias, liver disease and Type 1 diabetes, potentially allowing earlier medical intervention. However, incomplete medical records, data inconsistencies and false alerts remain major challenges.
Apollo Hospitals plans to add 5,800 beds over next five years, Gurugram facility to open in Q3 FY27
Apollo Hospitals is set to enhance its capacity by adding around 5,800 beds within the next five years. Their Gurugram facility, featuring approximately 470 beds, is expected to open by the third quarter of FY27.
Inside Park Hospitals' regional playbook: Why North India depth matters more than national reach
Park Hospitals is on an ambitious expansion journey, targeting around 6,600 beds by December 2028 across North India. Their strategy focuses on building hospitals in close proximity for better operational efficiency. The new Prayagraj initiative underscores a successful public-private partnership and illustrates their commitment to enhance healthcare capacity, ultimately improving patient care and resource management in the region.
Experts say health technology, preventive healthcare at inflection point, India ready to leverage
With a focus on preventive healthcare and wellness, India is on the verge of harnessing new technological innovations. Sangita Reddy from Apollo Hospitals stresses the significance of wearable devices in spotting health issues early on. In collaboration with Apollo Hospitals, Garmin Health is targeting rural health efforts and highlighting the event's health technology strides.
India's first public sector proton beam therapy unit to come up in Assam; state signs MoU with Belgian firm
Assam has signed an MoU with Belgium-based Ion Beam Applications (IBA) to set up India's first public-sector proton beam therapy centre in Guwahati at a cost of Rs 600 crore. The facility will offer advanced cancer treatment, particularly for children, and is expected to take at least three years to become operational.
Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: Report
Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision followed the discovery of failures in the company's quality management system. A joint inspection cited lapses that affected drug safety and quality, leading to a recall of several eye-drop brands. Significant adverse cases have raised concerns regarding product contamination, prompting further investigation.
Max Healthcare to add 209 beds with Rs 415 crore capex; Q2 network profit rises 10% to Rs 448 crore
Max Healthcare has approved a significant capital expenditure to expand bed capacity at its hospitals. The investments include adding 209 beds at three different locations to meet healthcare demands. BLK-Max Hospital will also feature a new multi-level parking tower as part of the expansion. In addition, the network's operational bed capacity has increased substantially over the past year. This expansion reflects the growing need for quality healthcare services across India.
Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini Piramal
In a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The company is actively diversifying its supply chains to provide greater flexibility against geopolitical challenges while broadening its manufacturing footprint to locations like India, the UK, and the US.
SC pulls up Centre over soaring medicine costs
The Supreme Court expressed concern over the government's role in allowing steep medicine prices to persist. Justices Vikram Nath and Sandeep Mehta questioned the justification for significant price discrepancies faced by patients. The court highlighted a lack of accountability regarding how drug manufacturers benefit from inflated prices. Government representatives stated that regulatory measures should not encompass the entire drug pricing ecosystem.
Must Watch
Healthware partners Fujifilm to expand use of precision surgical imaging solutions
Healthware has entered a partnership with Fujifilm to expand the use of intra-operative ultrasound systems across India. This collaboration aims to meet the critical clinical needs in complex surgeries. Real-time surgical ultrasound will be made available in more operating rooms, enhancing the speed of surgical procedures. The partnership combines technological innovation with clinical expertise for better patient outcomes. Healthware's national service and support network will facilitate this advancement in healthcare.
Cipla expects US business to draw support from upcoming product pipeline
Cipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fell by 19% due to increased competition impacting sales of generic Revlimid. However, Cipla anticipates that its upcoming product pipeline will support performance in North America. In India, domestic revenue rose, providing some resilience amidst challenges in the US market.
Power to empower must include the power to stay well
“The true value of power lies in its purpose,” the Prime Minister told the Bloomberg New Economy Forum in October. India’s next lever of power is the health of its people, and the digital infrastructure behind CoWIN can now help keep a billion Indians well.
Sakar Healthcare posts Rs 11 cr profit in Q2
The company said the second quarter growth was supported by new oncology approvals, strong demand across geographies, a better oncology mix, operating leverage, and disciplined cost management.
Lord’s Mark Industries Limited becomes Asia’s first company to secure multiple US FDA registrations for 200+ surgical and hygiene products; US exports to begin in December
Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its international footprint across the United States and South America
One Science Nutrition: Building a science-led approach to sports nutrition
One Science Nutrition was co-founded by Aman and Aniket Vachher to create credible sports nutrition products. The brand aims to cater to evolving consumer expectations around product quality and transparency. Their product range includes various supplements that support diverse fitness goals and health benefits. Future strategies involve leveraging artificial intelligence to enhance consumer experiences and product discovery. The founders emphasize maintaining core values while pursuing growth in the nutrition industry.
